NGS Sample Preparation Market - Global Forecast to 2024: Improving Reimbursement Scenario for NGS-Based Diagnostic Tests


Dublin, May 20, 2019 (GLOBE NEWSWIRE) -- The "NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2019, at a CAGR of 18.7% during the forecast period.

The growth of this market is driven by increasing application of NGS in diagnostics and genomics research, increasing adoption of NGS for diagnostics (due to the decreasing cost of NGS products and services), and development of low-cost sequencing technologies are expected to drive the market growth in the future.

NGS refers to non-Sanger-based high-throughput sequencing technologies. With the use of NGS technology, genomic material such as DNA strands can be sequenced simultaneously, yielding substantially more throughput; minimizing the need for fragment-cloning methods that are often used in Sanger sequencing of genomes. Sample preparation is an important step in the overall NGS workflow, which involves steps such as library preparation and target enrichment in order to prepare the libraries of samples to be sequenced.

Factors such as advancements in NGS platforms, reduced cost of sequencing, and improving reimbursement scenario for NGS-based diagnostic tests are driving the growth of this market. However, while the costs involved in NGS have reduced to some extent, they have not reached a level where broad adoption across developing markets can be achieved. This is a key restraint for market growth.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 NGS Sample Preparation: Market Overview
4.2 NGS Sample Preparation Market Share, By Product, 2018
4.3 Market, By End User, 2019 vs. 2024 (USD Million)
4.4 Market, By Application, 2019 vs. 2024 (USD Million)
4.5 Market, By Region

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in NGS Platforms
5.2.1.2 Declining Cost of Sequencing
5.2.1.3 Improving Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints
5.2.2.1 End User Budget Constraints in Developing Countries
5.2.3 Opportunities
5.2.3.1 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
5.2.3.2 Increasing Applications of NGS
5.2.4 Challenges
5.2.4.1 Ethical Issues

6 NGS Sample Preparation Market, By Product
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Rising Adoption of NGS is Supporting the Use of NGS Reagents and Consumables
6.3 NGS Workstations
6.3.1 High Throughput and Reduction in Hands-On Time Ensures the Adoption of Workstations in NGS Workflow

7 NGS Reagents and Consumables Market, By Workflow
7.1 Introduction
7.2 Library Preparation
7.2.1 DNA Fragmentation, End Repair, A-Tailing, and Size Selection
7.2.1.1 Availability of Products From Various Players Drives the Market for This Segment
7.2.2 DNA Library Preparation
7.2.2.1 Whole Exome Sequencing
7.2.2.2 Targeted Sequencing
7.2.2.3 Whole Genome Sequencing
7.2.2.4 Others
7.2.3 RNA Library Preparation
7.2.3.1 Gene Expression Analysis
7.2.3.2 Whole Transcriptome Sequencing
7.2.3.3 Other RNA Applications
7.3 Target Enrichment
7.3.1 Targeted Sequencing
7.3.2 Whole Exome Sequencing
7.3.3 Others
7.4 Quality Control
7.4.1 Importance of Quality Control Step in the NGS Workflow & Rising Number of Research Activities Using NGS Technology are the Key Factors Driving Market Growth

8 NGS Library Preparation & Target Enrichment Market, By Technology
8.1 Introduction
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs has A Wide Customer Base Owing to Its Well-Established Precision in Sequencing as Well as Its Broad Application Base
8.3 Ion Semiconductor Sequencing
8.3.1 Extensive Applications of Ion Semiconductor Sequencing to Drive Market Growth
8.4 Single-Molecule Real-Time Sequencing (Smrt)
8.4.1 High Cost of Smrt-Based Platforms to Restrain Market Growth
8.5 Nanopore Sequencing
8.5.1 Small Size and Low Equipment Costs to Support the Adoption of Nanopore Sequencing Platforms By Various End Users
8.6 Other Sequencing Technologies

9 NGS Sample Preparation Market, By Application
9.1 Introduction
9.2 Diagnostics
9.2.1 Cancer Diagnostics
9.2.1.1 Increasing Cancer Patient Population Across the Globe is Driving This Segment
9.2.2 Infectious Disease Diagnostics
9.2.3 Reproductive Health Diagnostics
9.2.4 Other Disease Diagnostic Applications
9.3 Drug Discovery
9.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery and Development to Drive the Adoption NGS Sample Preparation Products
9.4 Agricultural & Animal Research
9.4.1 Funding & Support for Animal and Plant Genomics Research to Support the Adoption of NGS Sample Preparation Products
9.5 Other Applications

10 NGS Sample Preparation Market, By End User
10.1 Introduction
10.2 Academic Institutes & Research Centers
10.2.1 Availability of Financial Support for Genomics Research to Support the Growth of This Segment
10.3 Hospitals & Clinics
10.3.1 NGS Technology to Witness Significant Adoption in Disease Diagnosis Owing to Its Advantages Over Conventional Methods
10.4 Pharmaceutical & Biotechnology Companies
10.4.1 Continuous Focus of Pharmaceutical and Biotechnology Companies on Targeted therapies for Precision Medicine to Drive the Growth of ThisEnd-User Segment
10.5 Other End Users

11 NGS Sample Preparation Market, By Region
11.1 Introduction
11.2 North America
11.3 US
11.3.1 Favorable Regulatory and Reimbursement Scenario for NGS-Based Diagnostics Tests in the Country Drives the Market
11.4 Canada
11.4.1 Favorable Government Funding Scenario in Canada Boost Genomics Research
11.5 Europe
11.6 Germany
11.6.1 Strong R&D Base in Germany Supports Market Growth
11.7 UK
11.7.1 Use of NGS-Based Test for Disease Diagnosis Will Drive Market Growth
11.8 France
11.8.1 Support for Genomics Research is A Key Driver of Market Growth
11.8.2 RoE
11.9 Asia Pacific
11.9.1 China
11.9.2 Japan
11.9.3 India
11.9.4 Rest of Asia Pacific
11.10 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis, 2018
12.3 Competitive Scenario
12.4 Vendor Inclusion Criteria
12.5 Competitive Leadership Mapping (Overall Market - 2017)

13 Company Profile
13.1 Agilent Technologies, Inc.
13.2 Becton, Dickinson and Company
13.3 Beckman Coulter (A Subsidiary of Danaher)
13.4 F. Hoffmann-La Roche AG
13.5 Illumina, Inc.
13.6 New England Biolabs, Inc.
13.7 Nugen Technologies, Inc. (Part of Tecan Trading Ag)
13.8 Oxford Gene Technology (Part of Sysmex)
13.9 Oxford Nanopore Technologies, Ltd.
13.10 Pacific Biosciences of California, Inc.
13.11 Perkinelmer, Inc.
13.12 QIAGEN N.V.
13.13 Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)
13.14 Swift Biosciences Inc.
13.15 Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/juzryy

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


            

Contact Data